Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells

Endometrial cancers expressing estrogen and progesterone receptors respond to hormonal therapy. The disappearance of steroid hormone receptor expression is common in patients with recurrent disease, ultimately hampering the clinical utility of hormonal therapy. Here, we demonstrate for the first tim...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Lin, Chiao-Yun, Chao, Angel, Wang, Tzu-Hao, Lee, Li-Yu, Yang, Lan-Yan, Tsai, Chia-Lung, Wang, Hsin-Shih, Lai, Chyong-Huey
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312367/
https://ncbi.nlm.nih.gov/pubmed/27527851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11048
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars